Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus - Clinical Trial NCTNCT04877691

Business Opportunities for NCT04877691

Connect with principal investigators, study coordinators, and key decision makers for this PHASE3 trial studying investigational therapy for Lupus Erythematosus, Systemic.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Lupus Erythematosus, Systemic

Study Phase

PHASE3

Study Status

ACTIVE_NOT_RECRUITING

NCT Number

NCTNCT04877691

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 140 locations across United States, Argentina, Bulgaria, Chile, Colombia, Germany, Hungary, Japan, Mexico, Philippines, Poland, Spain, Thailand, Ukraine, United Kingdom.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships